Routine mammography is associated with earlier stage disease and greater eligibility for breast conservation in breast carcinoma patients age 40 years and older

Cancer

Volumn 98, Issue 5, 2003, Pages 918-925

  Freedman, Gary M ^a   Anderson, Penny R ^a   Goldstein, Lori J ^a   Hanlon, Alexandra L ^a   Cianfrocca, Mary E ^a   Millenson, Michael M ^a   Von Mehren, Margaret ^a   Torosian, Michael H ^a   Boraas, Marsha C ^a   Nicolaou, Nicos ^a   Patchefsky, Arthur S ^a   Evers, Kathryn ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Breast carcinoma; Breast conservation; Cancer detection; Mammography

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CARCINOMA IN SITU; EARLY CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TUMOR VOLUME;

ADULT; AGE FACTORS; BREAST NEOPLASMS; CARCINOMA; ELIGIBILITY DETERMINATION; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM STAGING; PATIENT CARE PLANNING; PROSPECTIVE STUDIES;

EID: 0042889283     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11605     Document Type: Article

References (48)

1. U.S. Preventive Services Task Force. Screening for breast cancer: recommendations and rationale. Ann Intern Med. 2002;137:344-346.
2. von Eschenbach AC. NCI remains committed to current mammography guidelines. Oncologist. 2002;7:170-171.
3. National Comprehensive Cancer Network. NCCN practice guidelines for breast cancer. Oncology. 2000;14:33-49.
4. American College of Radiology. Standards 2001-2002. Reston, VA: American College of Radiology, 2002.
5. Smith R, Saslow D, Sawyer K, et al. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin. 2003;53:141-169.
6. National Alliance of Breast Cancer Organizations. Early detection of breast cancer, 2002. Available at http://www.nabco.org/index.php/3
7. Susan G. Komen Foundation. Early Detection, 2002. Available at http://www.komen.org/bci/bhealth/EarlyDetection/BreastCancerDetection.asp
8. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002;359:909-919.
9. Alexander FE, Anderson TJ, Brown HK, et al. 14 years of follow-up from the Edinburgh randomized trial of breast-cancer screening. Lancet. 1999;353:1903-1908.
10. Shapiro S. Evidence on screening for breast cancer from a randomized trial. Cancer. 1977;39:2772-2782.
11. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst. 2000;92:1490-1499.
12. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med. 2002;137:305-312.
13. Boyd NF, Jong RA, Yaffe MJ, Tritchler D, Lockwood G, Zylak CJ. A critical appraisal of the Canadian National Breast Cancer Screening Study. Radiology. 1993;189:661-663.
14. Boyd NF. The review of randomization in the Canadian National Breast Screening Study. Is the debate over? CMAJ. 1997;156:207-209.
15. Burhenne LJ, Burhenne HJ. The Canadian National Breast Screening Study: a Canadian critique. AJR Am J Roentgenol. 1993;161:761-763.
16. Kopans D, Feig S. The Canadian National Breast Screening Study: a critical review. AJR Am J Roentgenol. 1993;161:755-760.
17. Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet. 2000;355:129-134.
18. Olsen O, Gøtzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet. 2001;358:1340-1342.
19. Begg CB. The mammography controversy. Oncologist. 2002;7:174-176.
20. Duffy SW, Tabár L, Smith RA. The mammographic screening trials: commentary on the recent work by Olsen and Gøtzsche. CA Cancer J Clin. 2002;52(2):68-72.
21. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography. A meta-analysis. JAMA. 1995;273:149-154.
22. Humphrey LL, Helfand M, Chan BKS, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:347-360.
23. Rimer BK. Breast cancer screening. In: Harris JR, Lippman ME, Morrow M, Hellman S, editors. Diseases of the breast. Philadelphia: Lippincott-Raven Publishers, 1996:307-322.
24. Tabár L, Vitak B, Chen HT, Yen M, Duffy SW, Smith RA. Beyond randomized controlled trials. Organized mammographic screening substantially reduces breast carcinoma mortality. Cancer. 2001;91:1724-1731.
25. Duffy SW, Tabár L, Chen H, et al. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. A collaborative evaluation. Cancer. 2002;95:458-469.
26. Feig S. Effect of service screening mammography on population mortality from breast carcinoma. Cancer. 2002;95:451-457.
27. Vacek PM, Geller BM, Weaver DL, Foster RS Jr. Increased mammography use and its impact on earlier breast cancer detection in Vermont, 1975-1999. Cancer. 2002;94:2160-2168.
28. Ernster VL, Ballard-Barbash R, Barlow WE, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst. 2002;94:1546-1554.
29. Stewart AK, Bland KI, McGinnis LS Jr., Morrow M, Eyre HJ. Clinical highlights from the National Cancer Data Base, 2000. CA Cancer J Clin. 2000;50:171-183.
30. Goldhirsch A, Glick JH, Gelber RD, Senn H-J. Meeting highlights: International consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst. 1998;90:1601-1608.
31. Rowland JH, Massie MJ. Patient rehabilitation and support. In: Harris JR, Lippman ME, Morrow M, Hellman S, editors. Diseases of the breast. Philadelphia: Lippincott-Raven Publishers, 1996:919-938.
32. Pasacreta J, McCorkle R, Margolis G. Psychosocial aspects of breast cancer. In: Fowble B, Goodman RL, Glick JH, Rosato EF, editors. Breast cancer treatment. A comprehensive guide to management. St. Louis: Mosby-Year Book, Inc., 1991:551-570.
33. Tabár L, Faberberg G, Day N, Holmberg L. What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer. 1987;55:547-551.
34. Tabár L, Faberberg G, Chen H, et al. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer. 1995;75:2507-2517.
35. Michaelson J, Halpern E, Kopans D. Breast cancer: computer simulation method for estimating optimal intervals for screening. Radiology. 1999;212:551-560.
36. Feig S. Increased benefit from shorter screening mammography intervals for women ages 40-49 years. Cancer. 1997;80:2035-2039.
37. Swedish Cancer Society and the Swedish National Board of Health and Welfare. Breast-cancer screening with mammography in women aged 40-49 years. Int J Cancer. 1996;68:693-699.
38. The Breast Screening Frequency Trial Group. The frequency of breast cancer screening: results from the UKCCCR Randomised Trial. Eur J Cancer. 2002;38:1458-1464.
39. Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol. 1998;16:441-452.
40. Fisher ER, Leeming R, Anderson S, Redmond C, Fisher B. Conservative management of intraductal carcinoma (DCIS) of the breast. J Surg Oncol. 1991;47:139-147.
41. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-1241.
42. Solin LJ, Fourquet A, Vicini F, et al. Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status. Int J Radiat Oncol Biol Phys. 2001;50:991-1002.
43. Silverstein M. Ductal carcinoma in situ of the breast: a surgeon's disease. Ann Surg Oncol. 1999;6:802-810.
44. Feig S. Ductal carcinoma in situ. Implications for screening mammography. Radiol Clin North Am. 2000;38:653-668.
45. Page D, Dupont W, Rogers L, Jensen R, Schuyler P. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer. 1995;76:1197-1200.
46. Michaelson JS, Silverstein M, Wyatt J, et al. Predicting the survival of patients with breast carcinoma using tumor size. Cancer. 2002;95:713-723.
47. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin. 2002;52:23-47.
48. Tabár L, Yen M, Vitak B, Chen H, Smith R, Duffy SW. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet. 2003;361:1405-1410.